Print Page   |   Sign In   |   Register
Newsletters
Blog Home All Blogs
Search all posts for:   

 

View all (114) posts »
 

Stock Market Manager Weekly Update: September 4th, 2019

Posted By Administration, Thursday, September 5, 2019

SMM Logo

               

 

 

 

Weekly Update: September 4th, 2019

http://www.valuengine.com/images/newsletter/weekly/facebook-icon-743200.jpg

http://www.valuengine.com/images/newsletter/weekly/TWITTERICON.jpg

http://ecomallymail.com/uploads/1524105419.png

6,462

520

472

6

11

 

 

Black Swan Connection Newsletter Signup


Breaking News

We dodged another one- As you can see from what a CAT 5 Hurricane did to the sparsely populated Bahamian islands, if there were a direct hit of this magnitude on the mainland US the death toll and devastation would be on a scale that is hard to comprehend. The destruction wrought by Michael last year and Irma before was substantial. I can’t help but believe that the global warming increasing summer ocean temperatures even slightly have had a dramatic impact on the severity of Hurricanes.

 

CNN 9-4-19

Hurricane Dorian threatens the US after devastating the Bahamas

Apocalyptic scenes emerge from the Bahamas as the rush for aid begins

Freeport, Grand Bahama (CNN)What used to be stunning islands are now scenes of widespread destruction.

Hurricane Dorian pulverized the northern Bahamas for two days, hurling catastrophic winds and relentless rain. It was the strongest storm ever to make landfall in the island nation.

"Nothing compares to what we went through the past two days," survivor Michael Hynes said. "Almost 48 hours now with nonstop carnage."

Read Complete Article


 

7-27-19 Antibe Therapeutics, Inc. TSXV:ATE, OTCQB:ATBPF)

Antibe Therapeutics Provides Update on Phase 2B Dose-Ranging, Efficacy Study for ATB-346

Antibe Therapeutics Inc. ("Antibe" or the “Company”) (TSXV: ATE, OTCQB: ATBPF), a leader in developing safer therapeutics for pain and inflammation, today provides an update on the Phase 2B dose-ranging, efficacy study for its lead drug, ATB-346. The clinical study commenced in March 2019 and is designed to validate the efficacy of ATB-346 in reducing pain and establish the dose for Phase 3 development. A total of 360 patients with osteoarthritis of the knee are being randomized to either placebo or one of three doses of ATB-346 administered once daily: 150 mg, 200 mg or 250 mg.

Read Complete Press Release

 

8-20-19 Canbiola, Inc. (OTCQB:CANB)
Canbiola Reports Second Quarter 2019 Results

Closed $3.9 Million Equity Raise Completed

HICKSVILLE, N.Y., Aug. 20, 2019 (GLOBE NEWSWIRE) -- Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the “Company”), a developer, manufacturer and seller of variety of hemp-derived THC-Free Cannabidiol (CBD) Isolate products such as oils, drops/tinctures, creams, moisturizers, chews, and capsules, announced today the company's financial results for the second quarter ended June 30, 2019.

Key Financial Highlights for Q2 2019:

  • Revenues increased by 311% to $633,579
  • Gross margin of 52.8%
  • Operating loss of $1,435,289, included $959,948 in non-cash stock-based compensation
  • Closed $3,936,700 cash raised subsequent to the end of the quarter

Read Complete Press Release

 

8-7-19 Trickle Research issues update and allocation increase to 6
Camino Minerals Corp  OTC: CAMZF TSXV: COR.V
12-24 Month Price Target $0.90

We initiated coverage of Camino in 2Q18 with the idea that they owned and were developing a copper resource in Peru that we felt held some characteristics that might suggest it could become amajor project. We submit, we have not provided much in terms of updates to the story, because frankly, there is not a lot to update beyond drilling and exploration results. On the other hand, they have made some management changes, they have obtained some key permits to continue the development and they are working on the second portion of a raise to support the whole project. To revisit, the initiating coverage included a handful of bullet points that we thought supported our enthusiasm for the project. Here are some of the highlights from that initiation as well as some new comments around those bullet points (The initiation excerpts are in italics.)

Camino’s current focus is on a Peruvian project they refer to as Los Chapitos (“Chapitos”). Chapito’s location is relatively benign in terms of some of the conflicts resource deals often face. That is, it is located in an area with little other commercial or other appeal, which we think is favorable from permitting and other environmental impact sort of issues. On the other hand, the property is also only about 10 miles north of Chala, Peru, which is a coastal town of about 4,500 people. Further, the project is about 400 miles south of Lima, (Peru’s capital and largest city) and along the Pan American Highway, so it is not so remote that it is untenable in terms of access to relevant resources. Chapitos is easily accessible from Chala via a handful of gravel roads connected to the Pam American Highway.

Read Complete Report

 

8-2-19 Canbiola, Inc. (OTCQB:CANB)

Canbiola Launches Dedicated Canbiola-Branded CBD Dispensing Machine

Initial 25 Units Will Target Medical Offices

HICKSVILLE, NY, Aug. 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the “Company”), a developer, manufacturer, and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, isolate, gel caps, and concentrate announced today the launch of its own Canbiola-branded CBD product dispensing machine. An initial order for the first 25 units has been placed with the installations expected to occur in August and September.

Read Complete Press Release

 

7-16-19 Antibe Therapeutics, Inc. TSXV:ATE, OTCQB:ATBPF)

Antibe Therapeutics Reports 2019 Year-End Financial and Operating Results

Antibe Therapeutics Inc. ("Antibe" or the “Company”) (TSXV:ATE, OTCQB:ATBPF) filed its financial and operating results on Tuesday, July 16 for the fourth quarter and the year ended March 31, 2019. The Company's audited 2019 consolidated financial statements, MD&A and AIF are available on SEDAR.

About Antibe Therapeutics Inc.
Antibe develops safer, non-addictive medicines for pain and inflammation. Antibe’s technology involves linking a hydrogen sulfide-releasing molecule to an existing drug to produce a patented, improved medicine. Antibe’s lead drug ATB-346 targets the global need for a safer, non-addictive drug for chronic pain and inflammation.

Read Complete Press Release

 

7-11-19 Trickle Research issues update and allocation increase to 7
AzurRx Biopharma, Inc.  NASDAQ AZRX
12-24 Month Price Target $10.25

AZRX made the following announcement the other day regarding a new clinical trial they are preparing. They also hosted a call to discuss the logic behind the trial. Here is that release: AzurRx BioPharma Announces Initiation of Phase 2 Clinical Study for MS1819-SD in combination with standard PERT for Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency

  • Dose escalation study of MS1819-SD in combination with standard porcine pancreatic enzyme replacement therapy (PERT) in CF patients with severe exocrine pancreatic insufficiency (EPI)
  • .Patients in study have persistent malnutrition and clinical symptoms of fat malabsorption despite being on the maximum daily doses of PERTs.
  • First patient visits have been completed in Hungary.
  • Preliminary data expected in early 2020.

NEW YORK, July 08, 2019 (GLOBE NEWSWIRE) --AzurRx BioPharma, Inc. (AZRX) (AzurRx or the Company), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, today announced that it has initiated a Phase 2 clinical trial to investigate MS1819-SD in combination with standard porcine enzyme replacement therapy (PERT) for patients with cystic fibrosis (CF) that suffer from severe exocrine pancreatic insufficiency (EPI), but continue to experience clinical symptoms of fat malabsorption despite taking the maximum daily dose of PERTs.

Read Complete Report

 

7-10-19 Endurance Exploration Group, Inc. (EXPL)
BWVI and EXPL Continue to Work Through 2019 Season

Jacksonville FL, July 10, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Blue Water Ventures International, Inc. (BWVI) and project partner Endurance Exploration Group, Inc. (EXPL), are well into the 2019 recovery season on the SB Pulaski.   The SB Pulaski sank in 1838 while in route from Savannah, Georgia to Baltimore, Maryland.  She carried some of the South’s wealthiest families.  The shipwreck was considered the “Titanic” of its’ day.  

The Blue Water Rose has been based out of Wrightsville Beach, North Carolina since mid June.  As weather permits, on site excavations have continued with the recovery of more silver and copper coins; most from US origins, a small gold pocket watch, silver ware and wreck material.  A more detailed survey of bottom conditions has shown Hurricane Florence (September 2018) had a bigger impact on the seabed than was earlier believed.   The Blue Water dive team will continue with a methodical recovery plan to ensure that the entire wreck area will be thoroughly recorded and searched.  Keith Webb, President of Blue Water Ventures International, states, “We are very encouraged with the magnetometer results that were conducted in June and have now established the debris line which should unlock the Pulaski’s secrets.” 

Read Complete Press Release

 

Donald Capital, LLC, A New Investment Bank Opens Its Doors

NEW YORK, May 16, 2019 (GLOBE NEWSWIRE) – Donald Capital, LLC has launched today as a FINRA member Investment Bank. Founded with the intent to build a legacy based upon the fundamentals of honesty and integrity.

Donald Capital will focus on a market that has not been properly served for some time – the Private, Micro, Small & Mid Cap Markets. 

Co-founders Alex Hamilton and Don McDonald have launched several initiatives over their extensive careers to serve this part of the market.  They are very familiar with the challenges facing companies in this market and have the unique perspective to provide solutions.

Read Complete Press Release

 

New Distribution Partner for SMM

In addition to our ongoing growth in distribution we have added a new very important distribution partner in Quote Media.

https://www.quotemedia.com/

They are the premier provider of quote and news services to the financial Industry in North America. They current have some 675 subscribers and publishers of their quote and news feeds including major stock exchanges like NASDAQ and the Toronto Stock Exchange and an extensive list of portfolio managers both in North America and abroad.

All Research updates, releases and news articles will automatically be uploaded from SMM to Quote Media through our RSS feed and will be then ticker tagged and distributed across the Quote Media network in real Time.

This is provided by SMM at no additional charge.

If you have any questions, please feel free to email or give me a call.

September 3-19

COMPANY QUOTES, LISTINGS RESEARCH AND NEWS

Company

   

Premium

Research

News

(listing, quotes, news, research)

 

Profile

Updates

Updates

Alvopetro Energy, Ltd. (ALVOF)

 

Profile

  06/20/19

News

Antibe Therapeutics, Inc (ATBPF)

 

 Profile

11/11/18

News

AzuerRx Biopharma, Inc. (AZRX)

 

07/11/19

News

Camino Minerals Corp. (CAMZF)

 

08/19/19

News

Canbiola, Inc. (CANB)

 

Profile

 

News

Clean Coal Technologies, Inc (CCTC)

Profile

 

News

Command Center , Inc. (CCNI)

   

11/13/18

News

Endurance Exploration Group, Ltd (EXPL)

 

 Profile

  07-10/19

News

Guangdong Land Holdings Limited (124) HK

06-06/19

News

H-Source Holdings, Ltd (HSCHF)

04/09/19         

News

Petroshare Corp. (PRHR)

 

08/23/18

 

Summit Wireless Technologies, Inc.

   

  06/04/19

News

Social Reality, Inc. (SRAX)

   

02/05/19

News

 

 

 


 

 

September 1st, 2019

ValuEngine Weekly Report

By: Paul Henneman

ValuEngine Market Valuation update for the week of August 30, 2019. Strong Buy stock pick for the week is ticker SHOP (Shopify Inc). As always ValuEngine data is updated daily and accounts for the recent activity in the markets. Read on for full updated numbers and stock pick. Read more

www.ValuEngine.com to log in, or free two-week full trial. Over 5,000 stocks, 16 sector groups, 140 plus industries covered every day.
 

Categories Uncategorized, Weekly NewsletterTags market valuations, markets, sector, sector valuations, sectors, stock market, stock pick, STRONG BUY, STRONG BUY stocks, valuations, valuengine, ZNGA, Zynga

VALUATION WATCH: Overvalued stocks now make up 28.09% of our stocks assigned a valuation and 10.94% of those equities are calculated to be overvalued by 20% or more.

 

To subscribe to our bulletins and receive content whenever it is published, subscribe at our blog HERE

Want to learn more about ValuEngine? Our methods? Our history? 
Check out our video presentation HERE

SMM Research Partners

 

Black Swan Research Coverage and Subscription Service
Click Here>>

 

Event Calendar Updates

The National Investment Banking Association (NIBA) is proud to host its 147th investment conference on November 12-13, 2019 at The Westin New York at Times Square in New York, NY.
Click Here for Details

 

The Rocky Mountain Microcap sponsored by GVC Capital and Dave Lavigne at Trickle Research LLC Conference will be held Nov 14-2019 at Coors Field in Denver.

Check back for details

 

Visit our homepage for up to the minute Financial News, Quotes and our Latest Black Swan Connection Newsletter

Stock Market Manager Homepage

-SMM Distribution Update-

Distribution (Reach)

SMM Global Twitter Acct     (Impressions last 30 days)          520

SMM Global Facebook Page  (Reach last-30 days)               6,462

SMM Linkedin Page                 (contacts)                              472

SMM Youtube Channel            (followers)                                 6 

SMM Instagram Page  *          (followers)                               11

Direct Email     *                                                          249,000

Total                                                                           256,460

Note*  Our Instagram acct was recently hacked so we had to start over again.

We have also cleansed our email database of subscribers who haven’t opened for some time and or have errors or other delivery issues with their email.

Black Swan Connection Newsletter Signup

ABOUT US

This post has not been tagged.

Share |
Permalink | Comments (0)
 
Community Search
Sign In